Some States Limit Monoclonal Antibody Treatment to High-Risk, Unvaccinated Patients

At least two states are recommending that doctors prioritize the limited supply of monoclonal antibody treatments for high-risk COVID-19 patients, including unvaccinated people who face severe disease.